Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.

Peter SchullianEdward JohnstonGregor LaimerDaniel PutzerGernot EberleYannick ScharllClaudia Ianetti-HacklReto Bale

Published in: Cardiovascular and interventional radiology (2021)

SRFA is a safe, minimally invasive treatment option in the management of BCLMs, especially in younger patients without advanced extrahepatic metastasis, including those with large liver tumors.

Keyphrases

radiofrequency ablation
liver metastases
minimally invasive
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
combination therapy
patient reported